Credit Agricole Starts Bio-Rad Labs (BIO) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $384.40 -0.19%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 27 | New: 16
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 27 | New: 16
Join SI Premium – FREE
Credit Agricole initiates coverage on Bio-Rad Labs (NYSE: BIO) with a Buy. PT $158.
For more ratings news on Bio-Rad Labs click here and for the rating history of Bio-Rad Labs click here.
Shares of Bio-Rad Labs closed at $124.32 yesterday.
For more ratings news on Bio-Rad Labs click here and for the rating history of Bio-Rad Labs click here.
Shares of Bio-Rad Labs closed at $124.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Starts Anthropic (ANT), Defers Offering Rating
- Bio-Rad to Participate in Fireside Chat During UBS Global Healthcare Conference
- HSBC Upgrades FedEx (FDX) to Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit AgricoleSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
